Photo: James E. Crowe, Jr., MD
James E. Crowe, Jr., MD
Year elected: 2004
Current membership category: Senior
Vanderbilt Vaccine Center
11475 MRB IV
2213 Garland Avenue
Nashville, TN 37232-0417
United States of America
Phone: 615-343-8064

Honors and awards

National Academy of Medicine (2014)
ASCI | Stanley J. Korsmeyer Award (2017) in recognition for research leading to the development of innovative technologies for the isolation and study of antiviral antibodies and for significantly advancing the fields of virology and immunology.
ASCI | Harrington Prize for Innovation in Medicine (2022) for breakthrough innovations in the use of human antibodies to treat COVID-19 (shared with Michel C. Nussenzweig) More

Biographical statement

Dr. Crowe is Director of the Vanderbilt Vaccine Center and the Ann Scott Carell Professor of Pediatrics, Pathology, Microbiology and Immunology at Vanderbilt University Medical Center. He is a board certified pediatric infectious diseases physician and viral immunology researcher.

Dr. Crowe's laboratory studies the human immune response to infection for a wide variety of major human pathogens, including many emerging infections. His research group uses a very broad array of techniques including molecular and cellular biology, state-of-the-art imaging and flow cytometry, bioinformatics, and bioengineering approaches to attack scientific problems at the forefront of immunity research.

Dr. Crowe is an elected member of the National Academy of Medicine and has been the recipient of numerous investigator awards including the 2017 ASCI Stanley J. Korsmeyer Award, the 2019 Merck Future Insight Prize, 2020 AAAS Golden Goose Award, and others. A number of vaccine candidates and human monoclonal antibodies developed in the course of his team’s research have been tested in Phase I-III clinical trials in humans.

Institutional affiliations

Christopher S. Williams, MD, PhD is the representative at this institution.


Infectious Disease

Positions held